Elrexfio
elranatamab-bcmm
- Strength
- 44 mg/1.1mL
- Form
- Injection, Solution
U.S. Pharmaceuticals
Not stocked by us — reference only
elranatamab-bcmm
Listed by Pfizer Laboratories Div Pfizer Inc
| Dosage form | Injection, Solution |
|---|---|
| Route | Subcutaneous |
| Approval route | BLA — biologic licence |
| NDC code | 0069-2522 |
| FDA application | BLA761345 |
| RxNorm concept | 2644885 |
| Package sizes listed | 1 |
| Marketed since | August 2023 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.